NASDAQ Biotechnology Index (^NBI)
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in NASDAQ Biotechnology Index, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
NASDAQ Biotechnology Index (^NBI) returned -7.34% year-to-date (YTD) and -8.79% over the past 12 months. Over the past 10 years, ^NBI returned 0.81% annually, underperforming the S&P 500 benchmark at 10.31%.
^NBI
-7.34%
3.57%
-16.97%
-8.79%
-0.20%
0.81%
^GSPC (Benchmark)
-4.26%
11.24%
-5.02%
8.55%
14.02%
10.31%
Monthly Returns
The table below presents the monthly returns of ^NBI, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | 5.15% | -0.32% | -6.06% | 0.38% | -6.25% | -7.34% | |||||||
| 2024 | 0.33% | 0.99% | 0.03% | -6.04% | 5.74% | 3.28% | 6.56% | 0.79% | -2.34% | -2.47% | -0.11% | -7.19% | -1.37% |
| 2023 | 3.50% | -6.55% | 1.23% | 1.50% | -2.73% | 0.10% | 1.30% | -0.37% | -3.91% | -6.56% | 4.87% | 12.82% | 3.74% |
| 2022 | -12.63% | -4.12% | 4.25% | -9.73% | -1.32% | 1.02% | 4.11% | -1.06% | -2.44% | 8.91% | 5.87% | -3.01% | -11.68% |
| 2021 | 6.25% | -2.37% | -4.29% | 2.97% | -2.03% | 8.00% | -0.20% | 4.09% | -4.91% | -1.89% | -3.95% | -0.45% | 0.23% |
| 2020 | -5.60% | 0.30% | -5.38% | 14.97% | 8.45% | 1.61% | -1.70% | 0.90% | -0.13% | -3.73% | 11.14% | 4.49% | 25.69% |
| 2019 | 13.40% | 2.67% | -0.88% | -4.82% | -6.10% | 9.20% | -3.08% | -2.64% | -3.30% | 7.73% | 11.44% | 0.84% | 24.41% |
| 2018 | 6.96% | -5.36% | -1.28% | -2.97% | 4.69% | 1.35% | 6.17% | 4.81% | -0.19% | -14.60% | 4.69% | -11.25% | -9.32% |
| 2017 | 4.96% | 6.79% | -1.23% | 1.48% | -3.95% | 8.49% | 2.90% | 4.53% | 0.06% | -5.81% | 0.54% | 1.47% | 21.06% |
| 2016 | -21.01% | -4.87% | 2.51% | 2.87% | 4.22% | -7.88% | 12.43% | -2.98% | 3.02% | -11.38% | 6.78% | -3.21% | -21.68% |
| 2015 | 5.90% | 4.90% | 1.91% | -2.75% | 9.24% | 1.13% | 3.58% | -10.58% | -11.46% | 7.61% | 2.57% | 1.21% | 11.42% |
| 2014 | 8.41% | 7.63% | -10.70% | -2.69% | 4.21% | 7.30% | -2.34% | 10.26% | -1.16% | 8.52% | 2.48% | -0.07% | 34.10% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current rank of ^NBI is 11, meaning it’s performing worse than 89% of other indices on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for NASDAQ Biotechnology Index (^NBI) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the NASDAQ Biotechnology Index. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the NASDAQ Biotechnology Index was 74.70%, occurring on Jul 10, 2002. Recovery took 2681 trading sessions.
The current NASDAQ Biotechnology Index drawdown is 27.07%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -74.7% | Mar 7, 2000 | 587 | Jul 10, 2002 | 2681 | Mar 5, 2013 | 3268 |
| -39.4% | Jul 21, 2015 | 237 | Jun 27, 2016 | 973 | May 11, 2020 | 1210 |
| -38.5% | Aug 10, 2021 | 212 | Jun 13, 2022 | — | — | — |
| -31.85% | Feb 1, 1994 | 55 | Apr 20, 1994 | 319 | Jul 26, 1995 | 374 |
| -28.07% | Oct 14, 1997 | 222 | Aug 31, 1998 | 46 | Nov 4, 1998 | 268 |
Volatility
Volatility Chart
The current NASDAQ Biotechnology Index volatility is 12.14%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.